Filing Details
- Accession Number:
- 0001209191-17-023533
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-29 16:54:08
- Reporting Period:
- 2015-03-16
- Filing Date:
- 2017-03-29
- Accepted Time:
- 2017-03-29 16:54:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1044378 | Biocept Inc | BIOC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1026765 | Ivor Royston | C/O Biocept, Inc. 5810 Nancy Ridge Drive #150 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-16 | 5,667 | $8.76 | 17,294 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 34,584 fewer shares.
- The number of shares and purchase price shown in column 4 above are reflected on a post-split basis.
- The number of shares reflected in column 5 above reflects the Reporting Person's ownership as of March 29, 2017.